Cart
sales@molnova.com
Home - Products - Microbiology/Virology - HIV - DMJ-I-228

DMJ-I-228

CAS No. 1374035-59-2

DMJ-I-228( +)-DMJ-I-228 )

Catalog No. M11542 CAS No. 1374035-59-2

A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    DMJ-I-228
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
  • Description
    A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    +)-DMJ-I-228
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1374035-59-2
  • Formula Weight
    435.84
  • Molecular Formula
    C19H19ClFN5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=C(Cl)C(F)=C1)C(N[C@@H]2[C@@H](NC(N)=N)CC3=C2C=CC=C3)=O.O=CO
  • Chemical Name
    N1-(4-chloro-3-fluorophenyl)-N2-((1S,2S)-2-guanidino-2,3-dihydro-1H-inden-1-yl)oxalamide formate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Madani N, et al. Structure. 2008 Nov 12; 16(11):1689-701. 2. Richard J, et al. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94. 3. LaLonde JM, et al. J Med Chem. 2012 May 10;55(9):4382-96.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • YIR-819 TFA salt

    YIR-819 is a small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 2.6 uM against YTA48P virus with no significant cytotoxicity (CC50=33 uM).

  • NBD-14107

    A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction.

  • Etravirine

    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.

Sign In Join Free